JP2024530268A5 - - Google Patents

Info

Publication number
JP2024530268A5
JP2024530268A5 JP2024510725A JP2024510725A JP2024530268A5 JP 2024530268 A5 JP2024530268 A5 JP 2024530268A5 JP 2024510725 A JP2024510725 A JP 2024510725A JP 2024510725 A JP2024510725 A JP 2024510725A JP 2024530268 A5 JP2024530268 A5 JP 2024530268A5
Authority
JP
Japan
Prior art keywords
nutritional supplement
composition according
supplement composition
weight
aqueous medium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024510725A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024530268A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2022/073487 external-priority patent/WO2023025806A1/en
Publication of JP2024530268A publication Critical patent/JP2024530268A/ja
Publication of JP2024530268A5 publication Critical patent/JP2024530268A5/ja
Pending legal-status Critical Current

Links

JP2024510725A 2021-08-24 2022-08-23 重炭酸ナトリウム栄養補助食品 Pending JP2024530268A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP21192881 2021-08-24
EP21192881.7 2021-08-24
EP22176761 2022-06-01
EP22176761.9 2022-06-01
PCT/EP2022/073487 WO2023025806A1 (en) 2021-08-24 2022-08-23 Sodium bicarbonate nutritional supplement

Publications (2)

Publication Number Publication Date
JP2024530268A JP2024530268A (ja) 2024-08-16
JP2024530268A5 true JP2024530268A5 (enExample) 2025-08-22

Family

ID=83283239

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024510725A Pending JP2024530268A (ja) 2021-08-24 2022-08-23 重炭酸ナトリウム栄養補助食品

Country Status (8)

Country Link
US (1) US20230082078A1 (enExample)
EP (1) EP4391837A1 (enExample)
JP (1) JP2024530268A (enExample)
KR (1) KR20240048543A (enExample)
AU (1) AU2022333240A1 (enExample)
CA (1) CA3229733A1 (enExample)
MX (1) MX2024002268A (enExample)
WO (1) WO2023025806A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024170643A1 (en) * 2023-02-15 2024-08-22 Laminaria Group Ab Sodium bicarbonate product for childbirth labor

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6432450B1 (en) 1999-09-09 2002-08-13 Gerhard Gergely Effervescent granules with delayed effervescent effect
US20070218126A1 (en) 2006-03-16 2007-09-20 Tamer Laboratories, Inc. Compositions and Methods for Reducing Inflammation and Pain Associated with Acidosis
US20090092658A1 (en) * 2007-10-05 2009-04-09 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
EP2098124A1 (en) 2008-03-03 2009-09-09 Nestec S.A. Carbohydrate gel
FR2967578B1 (fr) * 2010-11-18 2012-12-28 Advicenne Pharma Composition pharmaceutique comportant des sels de citrate et de bicarbonate, et son utilisation pour le traitement de la cystinurie
RU2550927C2 (ru) 2012-04-26 2015-05-20 Открытое Акционерное Общество "Татхимфармпрепараты" Состав лекарственной композиции от кашля и способ его получения
WO2014065890A1 (en) * 2012-10-25 2014-05-01 Otc Nutrition Llc Fast dissolving solid calcium mineral supplement compositions and process of making
US12150465B2 (en) 2018-03-27 2024-11-26 Laminaria Group Ab Nutritional supplements
CN109430669A (zh) 2018-12-25 2019-03-08 江苏艾兰得营养品有限公司 提高耐力补充运动所需营养的泡腾片制剂及其制备方法
US12274284B2 (en) 2019-05-31 2025-04-15 Ivo Rischbieter High-energy food supplement based on inverted sugars and ergogenic products for use in physical activity and method for producing same

Similar Documents

Publication Publication Date Title
Qureshi et al. Carrageenan: A wonder polymer from marine algae for potential drug delivery applications
CN103228269B (zh) 软胶囊用成膜组合物
US5667802A (en) Antacid composition
Vandamme et al. The use of polysaccharides to target drugs to the colon
US5505966A (en) Therapeutical composition and process for its preparation
CN1131028C (zh) 一天一次的美托洛尔口服制剂
US5023245A (en) Improved niacin formulation
Ibrahim Advances in polysaccharide-based oral colon-targeted delivery systems: the journey so far and the road ahead
CA2304948C (en) Pharmaceutical composition for the treatment of inflammatory bowel disease
JP2002138035A (ja) カプセルの密封方法
CN1452481A (zh) 果胶膜组合物
Sande Pectin-based oral drug delivery to the colon
JP2023549177A5 (enExample)
JP2024530268A5 (enExample)
JPH02167220A (ja) 天然ポリマーを用いた徐放性製剤
JPS62420A (ja) 弾性被膜を有する安定な固形調剤及びその製造方法
CN106902093A (zh) 一种植物肠溶空心胶囊及其生产方法
JP2023548711A5 (enExample)
JPH0568446B2 (enExample)
CN1554330A (zh) 用于载药的魔芋葡甘聚糖-海藻酸钙微球及制备方法
Shoaib et al. Applications of polysaccharides in controlled release drug delivery system
Scholtz et al. More good news about polymeric plant-and algae-derived biomaterials in drug delivery systems
CN115737599A (zh) 一种结直肠释放肠菌微胶囊
Sharma et al. Use of natural superdisintegrant in mouth dissolving tablet-an emerging trend
JP7499232B2 (ja) 薬剤放出制御剤形